Hemostemix (CVE:HEM) Shares Pass Below 50-Day Moving Average – Here’s What Happened

Hemostemix Inc. (CVE:HEM)’s share price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$0.12 and traded as low as C$0.09. Hemostemix shares last traded at C$0.09, with a volume of 2,500 shares.

Hemostemix Trading Down 5.3 %

The company has a quick ratio of 0.48, a current ratio of 0.04 and a debt-to-equity ratio of -55.07. The stock’s fifty day moving average price is C$0.12 and its two-hundred day moving average price is C$0.13. The company has a market capitalization of C$13.12 million, a PE ratio of -2.62 and a beta of 0.20.

Insiders Place Their Bets

In related news, Director Peter Alan Lacey acquired 200,000 shares of Hemostemix stock in a transaction that occurred on Thursday, March 6th. The stock was bought at an average price of C$0.15 per share, with a total value of C$30,000.00. 10.43% of the stock is currently owned by company insiders.

Hemostemix Company Profile

Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.